SB 480: RELATING TO HEALTH.
- Session Year: 2025-2026
- House: Senate
Current Status:
In Progress
(2025-02-10: The committee on HHS deferred the measure.)
Introduced
First Committee Review
First Chamber
Second Committee Review
Second Chamber
Final Decking
Enacted
Version:
Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.
Discussed in Hearing
11MINFeb 10, 2025
Senate Standing Committee on Health and Human Services
11MINFeb 10, 2025